Nagib Ahsan
Nagib Ahsan, PhD

Assistant Professor of Medicine (Research); Proteomics

Gabriella Ballester, MD

Hematology Oncology

Peter Barth
Peter Barth, MD

Hematology Oncology

Paul Bertone, PhD

Core Director (Single Cell Technologies); TRDG Member, Bioinfomatics Single cell profiling

Theo Brogovan, MD

Hematology Oncology

James Butera
James Butera, MD

Hematology Oncology

Benedito Carneiro
Benedito Carneiro, MD

Group Leader (Cancer Therapeutics); TRDG Leader (GU Cancer); Director, Phase I Clinical Research Program, Cell death targeted therapeutics, Immunotherapy

Patrycja Dubielecka-Szczerba
Patrycja Dubielecka-Szczerba, PhD

Core Director (CyTOF); Stem cell biology, Abl kinase, Bone marrow microenvironment

Pamela Egan
Pamela Egan, MD

Barriers to Care in Palliative Setting

Wafik El-Deiry
Wafik El-Deiry, MD, PhD, FACP

Director, Joint Program in Cancer Biology; TRDG Leader and Facilitator, Drug Discovery, Signaling, drug resistance, TRAIL, p53, p21, ONC201

Loren Fast
Loren Fast, PhD

Associate Professor Emeritus of Medicine

Liz Hernandez Borrero, PhD candidate

Translational theraputics

Cynthia Jackson
Cynthia Jackson, PhD

Clinical Pathology, Molecular Diagnostics, Molecular Pathology

Aakash Jhaveri, MS candidate

Translational Therapeutics

Habibe Kurt
Habibe Kurt, MD

Hematology Oncology

Mark LeGolvan, DO

Hematology Oncology

Olin Liang, PhD

Core Director (Lentivirus); Endothelial-tohematopoietic transition, Stem Cell Biology

Thomas Ollila, MD

Opioid dependence, Survivorship

Adam Olszewski
Adam Olszewski, MD

Treatment effects from secondary data, Hematological Malignancies

Nimesh Patel
Nimesh Patel, MD

Director, Mol Pathology, Lifespan, NGS, informatics tools, Genomics of solid tumors

Matthew Quesenberry
Matthew Quesenberry

Hematology Oncology

Peter Quesenberry
Peter Quesenberry, MD

TRDG Leader, Extracellular Vesicles, Hematological malignancies

John Reagan
John Reagan, MD

TRDG Leader (Hematological Malignancies), Hematological malignancies Immune therapies

Howard Safran, MD

Group Leader (Cancer Therapeutics); TRDG Leader and Facilitator, Medical Director, BrUOG, Chief, Hematology/Oncology, Brown and Lifespan, GI and brain cancer therapeutics, Experimental therapeutics

Neil Sarkar
Neil Sarkar, PhD

Group Leader (Population Science); Biomedical Informatics, Health Services and Policy

Attila A Seyhan, PhD

Director of Translational Oncology Operations, Joint Program in Cancer Biology, Brown University and Lifespan Cancer Institute; Core Director of Translational Oncology; Adjunct Associate Professor, Tumor metabolism and RNA processing

Robert Sokolic
Robert Sokolic, MD

Hematology Oncology

Joseph Sweeney
Joseph Sweeney, MD

Hematology Oncology

Xiaobing Tian, PhD

Core Director (Organic Synthesis); Research Assistant Professor, Integrated stress response, Cell signaling, Myc, Puma, p53

Diana Treaba, MD

Leukemia, Lymphoma, Clinical pathology

Dilber Ece Uzun
Dilber Ece Uzun, PhD

Clinical bioinformatics, Drug absorption

Alper Uzun
Alper Uzun, PhD

Assistant Professor of Pediatrics (Research)

Sicheng Wen, PhD

Hematopoietic Stem Cells and Aging

Mamiko Yajima
Mamiko Yajima, Md, PhD

Developmental Biology, Developmental Plasticity

Shengliang Zhang, MD, PhD

Core Director (Drug Discovery); Research Assistant Professor, ROS, ERK2, MDM2, p53

Yiqun Zhang, PhD

Translational Therapeutics

Shuai Zhao, PhD candidate

Translational Therapeutics

Lanlan Zhou, MD, PhD

Core Director (Organoids); Research Assistant Professor), Translational therapeutics, Biomarkers